NO20000961L - Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav - Google Patents

Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav

Info

Publication number
NO20000961L
NO20000961L NO20000961A NO20000961A NO20000961L NO 20000961 L NO20000961 L NO 20000961L NO 20000961 A NO20000961 A NO 20000961A NO 20000961 A NO20000961 A NO 20000961A NO 20000961 L NO20000961 L NO 20000961L
Authority
NO
Norway
Prior art keywords
well
preparation
methods
new tissue
specific
Prior art date
Application number
NO20000961A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000961D0 (no
Inventor
Thomas Boehm
Neil T Dear
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20000961D0 publication Critical patent/NO20000961D0/no
Publication of NO20000961L publication Critical patent/NO20000961L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96466—Cysteine endopeptidases (3.4.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Analytical Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
NO20000961A 1997-08-26 2000-02-25 Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav NO20000961L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19737105A DE19737105A1 (de) 1997-08-26 1997-08-26 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung
PCT/EP1998/005275 WO1999010480A2 (de) 1997-08-26 1998-08-19 Neue gewebsspezifische calpaine, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
NO20000961D0 NO20000961D0 (no) 2000-02-25
NO20000961L true NO20000961L (no) 2000-04-14

Family

ID=7840195

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000961A NO20000961L (no) 1997-08-26 2000-02-25 Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav

Country Status (13)

Country Link
EP (1) EP1009811A2 (de)
JP (1) JP2001513992A (de)
KR (1) KR20010023282A (de)
CN (1) CN1277634A (de)
AU (1) AU9263598A (de)
BR (1) BR9811365A (de)
CA (1) CA2301815A1 (de)
DE (1) DE19737105A1 (de)
HU (1) HUP0004027A2 (de)
IL (1) IL134361A0 (de)
NO (1) NO20000961L (de)
WO (1) WO1999010480A2 (de)
ZA (1) ZA987660B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928021A1 (de) * 1999-06-18 2000-12-21 Basf Ag Neue Calpaine und deren Verwendung
AU7476900A (en) * 1999-09-09 2001-04-10 Millennium Pharmaceuticals, Inc. 26176, a novel calpain protease and uses thereof
WO2001073073A2 (en) * 2000-03-28 2001-10-04 Bayer Aktiengesellschaft Regulation of human neutral protease-related enzyme
AUPQ656500A0 (en) * 2000-03-28 2000-04-20 Autogen Pty Ltd A method of treatment and agents for same
CA2479780A1 (en) * 2001-04-04 2002-10-17 Universite De Montreal Antisense calpain nucleotides and uses thereof
JP4593404B2 (ja) * 2005-08-29 2010-12-08 シスメックス株式会社 液体試料吸引監視方法及び装置、並びに液体試料分析装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE268816T1 (de) * 1994-07-15 2004-06-15 Cephalon Inc In baculovirus exprimiertes aktives calpain
EP0799892A3 (de) * 1996-04-05 1998-08-12 Takeda Chemical Industries, Ltd. Calpain, seine Herstellung und Verwendung

Also Published As

Publication number Publication date
KR20010023282A (ko) 2001-03-26
CN1277634A (zh) 2000-12-20
HUP0004027A2 (en) 2001-03-28
BR9811365A (pt) 2000-08-22
ZA987660B (en) 2000-02-25
NO20000961D0 (no) 2000-02-25
CA2301815A1 (en) 1999-03-04
IL134361A0 (en) 2001-04-30
AU9263598A (en) 1999-03-16
EP1009811A2 (de) 2000-06-21
WO1999010480A3 (de) 1999-05-27
JP2001513992A (ja) 2001-09-11
DE19737105A1 (de) 1999-03-04
WO1999010480A2 (de) 1999-03-04

Similar Documents

Publication Publication Date Title
NO973009L (no) Fremgangsmåte for å inhibere kathepsin-k
DK0692610T3 (da) Borehulsredskab, borehulsglideventil og fremgangsmåde til stimulering af en underjordisk formation
EA199700186A1 (ru) Новые дипептидные амидины, используемые в качестве ингибиторов тромбина
NO975336L (no) Elastomerisk kompound omfattende silisiumbehandlet sot, og fremgangsmåte for fremstilling av slik
NO941182L (no) Fremgangsmåte og fluid, samt porös pakking for behandling av en underjordisk formasjon
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
DK0788356T3 (da) Fremgangsmåde og præparater til hæmning af proteinkinaser
EA199900162A1 (ru) Ингибиторы клеточной адгезии
IE840302L (en) 3-(5-aminopentyl)amino-1-benzazepin-2-one-1-alkanoic acids.
NO306482B1 (no) FremgangsmÕte for boring og sementering av en brönn
NO930044L (no) Fremgangsmaate til vurdering av formasjoner og borkronetilstander
NO973265D0 (no) Anordning for komplettering av underjordisk brönn og tilhörende fremgangsmåte
AU3005997A (en) Inhibitors of picornavirus 3c proteases and methods for their use and preparation
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
NO952967D0 (no) Tetningstilsats, fraktureringsfluid og fremgangsmåte for frakturering av en underjordisk formasjon
ATE250077T1 (de) Steroid sulfataseinhibitoren, verfahren zu ihrer herstellung und verwendung
BG109411A (en) METHOD FOR OBTAINING HIV-PROTEZATE INHIBITORS
AU2251892A (en) Inhibitors of picornavirus proteases
NO20000961L (no) Nye vevs-spesifikke calpainer, samt fremgangsmåte for fremstilling og anvendelse derav
DE69622404D1 (de) Bohrhammerkrone, einsatz, verwendung dieses einsatzes und verfahren zur erhaltung des durchmessers dieser bohrkrone
ZA977868B (en) Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors.
DK0914605T3 (da) Molekylemodel for VLA-4-inhibitorer
AU1199395A (en) Soil irrigation pipe, soil irrigation method using the same pipe, and method of supplying gas into soil
NO991097L (no) Nye fremgangsmÕter
NO981578D0 (no) FremgangsmÕte for hemming av plasminogenaktivatorhemmer I

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application